Determination of estramustine and its 17-keto metabolite in plasma by high-performance liquid chromatography.
A rapid, sensitive and specific high-performance liquid chromatographic (HPLC) assay was developed for the determination of estramustine and its 17-keto metabolite in plasma. The assay involves extraction of the compounds into hexane from plasma buffered to pH 9.0, the residue obtained by evaporation of the hexane extract is dissolved in the mobile phase hexane-ethanol (92.5:7.5) with HPLC analysis performed on a 5-micrograms silica gel column using a fluorescence detector with excitation at 195 nm and emission at wavelengths greater than 250 nm. The overall recoveries and limits of sensitivity for estramustine and the 17-keto metabolite are 74.7% and 40 ng/ml of plasma and 85.1% and 50 ng/ml of plasma, respectively. The method was used to obtain plasma concentration-time profiles in three subjects with prostatic cancer following oral administration of a single 7 mg/kg dose of estramustine phosphate.
D002851:Chromatography, High Pressure Liquid / Q000379:methods; D004961:Estramustine / Q000097:blood* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009588:Nitrogen Mustard Compounds / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy; D013050:Spectrometry, Fluorescence
D009588:Nitrogen Mustard Compounds; D004961:Estramustine